These data demonstrate that the CRISPR-mediated reduction of Lepr in the LH plays a significant role in enhancing vulnerability to HFD-induced obesity, consistent with our previous data using AAV shRNA-mediated Lepr knockdown. Here, LEPR is linked to obesity disorder.